Back To Schedule
Tuesday, June 20 • 10:30am - 11:45am
#229: Outcomes Standardization: An Imperative to Value Assessments

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-17-559-L04-P; CME 1.25; IACET 1.25; RN 1.25

Data from both premarket and postmarketing clinical trials and formal registries of medical products can be used to assess safety and effectiveness across the medical product life cycle. Sources outside of clinical trials, such as EHRs, can provide evidence of continued effectiveness when used in larger populations in the postmarketing setting. However, the lack of consistent outcome assessments is a potential barrier to evaluating safety and efficacy across the continuum of the product life cycle.

Learning Objectives

Discuss the gaps and challenges in the current environment resulting from a lack of outcomes standardization.


Richard Gliklich, MD


Standardizing Outcomes for Patient Registries: Early Results From the Outcome Measures Framework Pilot Test
Elise Berliner, PhD

Paul Stang, PhD, FISPE

John H. Powers, III, MD, FACP

avatar for Richard Gliklich

Richard Gliklich

Chief Executive Officer, OM1, United States
Dr. Richard Gliklich is the CEO of OM1, Inc., a real-world data, outcomes and technology company focused on using data and AI to accelerate medical research and personalize medicine, especially in chronic conditions. OM1 develops extensive data networks of participating practices... Read More →


Elise Berliner

Director, Technology Assessment Program, Agency For Healthcare Research and Quality (AHRQ)
Dr. Berliner is the Director of the Technology Assessment Program at the Agency for Healthcare Research and Quality (AHRQ). The Technology Assessment Program provides technology assessments to the Centers for Medicare & Medicaid Services (CMS) to inform Medicare coverage decisions... Read More →
avatar for John Powers

John Powers

Professor of Clinical Medicine, George Washington University School of Medicine
Dr. Powers is a physician/investigator and an internist and specialist in infectious diseases. Dr Powers has particular expertise in the design, conduct and analysis of clinical trials and has published numerous articles and book chapters in this area.
avatar for Paul Stang

Paul Stang

Vice President: Global Epidemiology, Janssen Research & Development, LLC
Currently VP Global Epidemiology at J&J; formerly VP Cerner Corporation, which he joined after co-founding and serving as CSO Galt Associates. Worked at Glaxo and SmithKline Beecham as well as clinical appointments in Neurology and Neurosurgery. Published widely in epidemiology with focus in neurosciences including psychi... Read More →

Tuesday June 20, 2017 10:30am - 11:45am CDT
N426c McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  10: Value-Access, Forum